Nina Eadie

Double‐Blind, Randomized, Placebo‐Controlled, Dose‐Response Study of the Safety and Efficacy of Botulinum Toxin Type A in Subjects with Crow's Feet

B. Ascher, M. Heckmann, N. Lowe, 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants.

M. Brin, J. Pogoda, G. Demos, 2009, Journal of the American Academy of Dermatology.

A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.

J. Carruthers, M. Menter, P. Walker, 2002, Journal of the American Academy of Dermatology.

Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Botulinum Toxin Type A for Patients with Glabellar Lines

J. Carruthers, A. Menter, M. Menter, 2003, Plastic and reconstructive surgery.

Treatment of glabellar lines with Botox (onabotulinumtoxinA): Development, insights, and impact

M. Brin, J. Carruthers, A. Blitzer, 2023, Medicine.

Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact

Markus Naumann, N. Lowe, Nina Eadie, 2023, Medicine.

Safety and tolerability of onabotulinumtoxinA in the treatment of facial lines: a meta-analysis of individual patient data from global clinical registration studies in 1678 participants.

M. Brin, J. Pogoda, G. Demos, 2009, Journal of the American Academy of Dermatology.

Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: a 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety.

J. Kowalski, N. Lowe, P. Lai, 2007, Journal of the American Academy of Dermatology.

Validity and reliability of the hyperhidrosis disease severity scale (HDSS)

J. Kowalski, P. Lai, N. Eadie, 2004 .